These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 8901374)
1. Impact of the global on patient perceivable change in an asthma specific QOL questionnaire. Barber BL; Santanello NC; Epstein RS Qual Life Res; 1996 Feb; 5(1):117-22. PubMed ID: 8901374 [TBL] [Abstract][Full Text] [Related]
2. Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma. Murphy KR; Fitzpatrick S; Cruz-Rivera M; Miller CJ; Parasuraman B Pediatrics; 2003 Sep; 112(3 Pt 1):e212-9. PubMed ID: 12949315 [TBL] [Abstract][Full Text] [Related]
3. [Utilization and clinical validation of the Spanish version of the Pediatric Asthma Quality of Life Questionnaire (PAQLQ) and the Diary for Caregivers of Asthmatic Children (DCA). VALAIR study]. Alonso Lebrero E Allergol Immunopathol (Madr); 2000; 28(3):175-83. PubMed ID: 10867390 [TBL] [Abstract][Full Text] [Related]
4. The impact of a medical food containing gammalinolenic and eicosapentaenoic acids on asthma management and the quality of life of adult asthma patients. Surette ME; Stull D; Lindemann J Curr Med Res Opin; 2008 Feb; 24(2):559-67. PubMed ID: 18194593 [TBL] [Abstract][Full Text] [Related]
5. Assessing the responsiveness of the Asthma Quality of Life Questionnaire with pharmaceutical care. Kheir NM; Emmerton L; Shaw JP Pharm World Sci; 2008 Aug; 30(4):322-8. PubMed ID: 18008177 [TBL] [Abstract][Full Text] [Related]
6. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366 [TBL] [Abstract][Full Text] [Related]
7. Early asthma prophylaxis, natural history, skeletal development and economy (EASE): a pilot randomised controlled trial. Baxter-Jones AD; Helms PJ; Russell G; Grant A; Ross S; Cairns JA; Ritchie L; Taylor R; Reid DM; Osman LM; Robins S; Fletcher ME Health Technol Assess; 2000; 4(28):1-89. PubMed ID: 11074396 [TBL] [Abstract][Full Text] [Related]
8. Improvement in quality of life with omalizumab in patients with severe allergic asthma. Chipps B; Buhl R; Beeh KM; Fox H; Thomas K; Reisner C Curr Med Res Opin; 2006 Nov; 22(11):2201-8. PubMed ID: 17076981 [TBL] [Abstract][Full Text] [Related]
9. An assessment of change in asthma control among adolescents and adults with persistent asthma in mometasone furoate/formoterol fumarate clinical trials. Wyrwich KW; Ireland AM; Navaratnam P; Nolte H; Gates DF J Asthma; 2011 Feb; 48(1):48-56. PubMed ID: 21039190 [TBL] [Abstract][Full Text] [Related]
10. Validation and agreement across four versions of the asthma control questionnaire in patients with persistent asthma. Wyrwich KW; Khan SA; Navaratnam P; Nolte H; Gates DF Respir Med; 2011 May; 105(5):698-712. PubMed ID: 21146389 [TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of an Asthma-Specific Quality of Life (A-QOL) questionnaire. Lee EH; Kim SH; Choi JH; Jee YK; Nahm DH; Park HS J Asthma; 2009 Sep; 46(7):716-21. PubMed ID: 19728212 [TBL] [Abstract][Full Text] [Related]
12. Dupilumab improves symptoms, quality of life, and productivity in uncontrolled persistent asthma. Corren J; Castro M; Chanez P; Fabbri L; Joish VN; Amin N; Graham NMH; Mastey V; Abbé A; Taniou C; Mahajan P; Teper A; Pirozzi G; Eckert L Ann Allergy Asthma Immunol; 2019 Jan; 122(1):41-49.e2. PubMed ID: 30138668 [TBL] [Abstract][Full Text] [Related]
13. Symptom control and improved functioning: the effect of omalizumab on asthma-related quality of life (ARQL). Luskin AT; Kosinski M; Bresnahan BW; Ashby M; Wong DA J Asthma; 2005 Dec; 42(10):823-7. PubMed ID: 16393718 [TBL] [Abstract][Full Text] [Related]
14. Assessment of the reliability, validity, and responsiveness of a Spanish Asthma Quality of Life questionnaire. Perpiñá M; Belloch A; Marks GB; Martinez-Moragón E; Pascual LM; Compte L J Asthma; 1998; 35(6):513-21. PubMed ID: 9751069 [TBL] [Abstract][Full Text] [Related]
15. Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels: A Randomized Phase 3 Study. Bjermer L; Lemiere C; Maspero J; Weiss S; Zangrilli J; Germinaro M Chest; 2016 Oct; 150(4):789-798. PubMed ID: 27056586 [TBL] [Abstract][Full Text] [Related]
16. The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma. Murphy K; Nelson H; Parasuraman B; Boggs R; Miller C; O'Dowd L Curr Med Res Opin; 2008 Mar; 24(3):879-94. PubMed ID: 18267051 [TBL] [Abstract][Full Text] [Related]
17. Breathing retraining for dysfunctional breathing in asthma: a randomised controlled trial. Thomas M; McKinley RK; Freeman E; Foy C; Prodger P; Price D Thorax; 2003 Feb; 58(2):110-5. PubMed ID: 12554890 [TBL] [Abstract][Full Text] [Related]
18. Factors associated with quality of life in patients with severe asthma: the impact of pharmacotherapy. Souza DS; Noblat Lde A; Santos Pde M J Bras Pneumol; 2015; 41(6):496-501. PubMed ID: 26785957 [TBL] [Abstract][Full Text] [Related]
19. Negative mood and quality of life in patients with asthma. Ekici A; Ekici M; Kara T; Keles H; Kocyigit P Qual Life Res; 2006 Feb; 15(1):49-56. PubMed ID: 16411030 [TBL] [Abstract][Full Text] [Related]
20. Omalizumab (Xolair) improves quality of life in adult patients with allergic asthma: a review. Buhl R Respir Med; 2003 Feb; 97(2):123-9. PubMed ID: 12587961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]